Eli Lilly (LLY) Curent Deferred Tax Liability (2011 - 2015)

Eli Lilly has reported Curent Deferred Tax Liability for 5 years, with the latest figure at $943.6 million in Q3 2015.

• For the quarter ending Q3 2015, Curent Deferred Tax Liability fell 30.23% year-over-year to $943.6 million; the trailing twelve-month figure through Sep 2015 stood at $943.6 million (down 30.23% YoY), and the FY2014 full-year result was $1.5 billion, up 84.98% from the prior year.
• Curent Deferred Tax Liability for Q3 2015 stood at $943.6 million, up from $912.8 million in the prior quarter.
• The five-year high for Curent Deferred Tax Liability was $1.5 billion in Q4 2014, with the low at $422.3 million in Q4 2011.
• Historically, Curent Deferred Tax Liability has averaged $963.2 million across 5 years, with a median of $913.6 million in 2013.
• Annual changes were most pronounced in 2012 — Curent Deferred Tax Liability surged 148.16% — and 2015, when it plunged 30.23%.
• Eli Lilly's Curent Deferred Tax Liability stood at $422.3 million in 2011, then surged by 148.16% to $1.0 billion in 2012, then decreased by 24.35% to $792.8 million in 2013, then jumped by 84.98% to $1.5 billion in 2014, then plunged by 35.66% to $943.6 million in 2015.
• The last three Curent Deferred Tax Liability figures came in at $943.6 million (Q3 2015), $912.8 million (Q2 2015), and $1.3 billion (Q1 2015), per Business Quant data.